Filing Details

Accession Number:
0001388658-20-000274
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-19 19:29:11
Reporting Period:
2020-11-17
Accepted Time:
2020-11-19 19:29:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388658 Irhythm Technologies Inc. IRTC Surgical & Medical Instruments & Apparatus (3841) 208149544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670676 A David Vort C/o Irhythm Technologies, Inc.
699 8Th St #600
San Francisco CA 94103
Evp, Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-17 5,000 $17.00 20,579 No 4 M Direct
Common Stock Disposition 2020-11-17 300 $224.26 20,279 No 4 S Direct
Common Stock Disposition 2020-11-17 600 $225.70 19,679 No 4 S Direct
Common Stock Disposition 2020-11-17 500 $226.70 19,179 No 4 S Direct
Common Stock Disposition 2020-11-17 2,697 $229.15 16,482 No 4 S Direct
Common Stock Disposition 2020-11-17 500 $230.39 15,982 No 4 S Direct
Common Stock Disposition 2020-11-17 200 $232.10 15,782 No 4 S Direct
Common Stock Disposition 2020-11-17 203 $233.89 15,579 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-11-17 5,000 $0.00 5,000 $17.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,777 2020-09-21 2026-10-20 No 4 M Direct
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $233.98 to $224.81 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. This transaction was executed in multiple trades at prices ranging from $225.43 to $226.09 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. This transaction was executed in multiple trades at prices ranging from $226.60 to $227.10 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. This transaction was executed in multiple trades at prices ranging from $228.92 to $229.80 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  6. This transaction was executed in multiple trades at prices ranging from $230.33 to $230.41 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  7. This option is fully vested and exercisable in full.